Insulin-like growth factor-I given subcutaneously reduces clinical deficits, decreases lesion severity and upregulates synthesis of myelin proteins in experimental autoimmune encephalomyelitis
Authors:
- Xia LiuXLXia Liu
- Lynn D. HudsonLHLynn D. Hudson
- Henry Def. WebsterHWHenry Def. Webster
- 1 March 1996
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 58 (16) , 1301-1306
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Insulin-like growth factor I treatment reduces clinical deficits and lesion severity in acute demyelinating experimental autoimmune encephalomyelitisMultiple Sclerosis Journal, 1995
- Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neuronsNeuron, 1995
- Cryogenic spinal cord injury induces astrocytic gene expression of insulin‐like growth factor I and insulin‐like growth factor binding protein 2 during myelin regenerationJournal of Neuroscience Research, 1995
- Astrocytes Express Insulin-like Growth Factor-I (IGF-I) and Its Binding Protein, IGFBP-2, during Demyelination Induced by Experimental Autoimmune EncephalomyelitisMolecular and Cellular Neuroscience, 1994
- Clinical Uses of Insulin-like Growth Factor IAnnals of Internal Medicine, 1994
- Concentric sclerosis (Baló): Morphometric and in situ hybridization study of lesions in six patientsAnnals of Neurology, 1994
- Effects of Multiple Subcutaneous Doses of rhIGF‐1 on Total and Free IGF‐1 Levels and Blood Glucose in HumansAnnals of the New York Academy of Sciences, 1993
- Insulin-like growth factor I increases brain growth and central nervous system myelination in tTransgenic miceNeuron, 1993
- Cell death and control of cell survival in the oligodendrocyte lineageCell, 1992
- Insulin‐like growth factor I promotes cell proliferation and oligodendroglial commitment in rat glial progenitor cells developing in vitroJournal of Neuroscience Research, 1988